9. A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements. Kee C.L., Ge X., Gilard V., Malet-Martino M., Low M.Y.
J. Pharm. Biomed. Anal.,
2018, 147, 250-277
.
8. Pulsed-field gradient nuclear magnetic resonance measurements (PFG NMR) for diffusion ordered spectroscopy (DOSY) mapping. Pagès G., Gilard V., Martino R., Malet-Martinon M.
Analyst,
2017,142, 3771-3796
.
7. Screening of "spice" herbal mixtures: From high-field to low-field proton NMR.
Assemat G., Dubocq F, Balayssac S., Lamoureux C., Malet-Martino M., Gilard V.
Forensic Science International,
2017, 279, 88-95.
6. Green microparticles based on a chitosan/lactobionic acid/linoleic acid association. Characterisation and evaluation as a new carrier system for cosmetics. Chaouat C., Balayssac S., Malet-Martino M., Belaubre F., Questel E., Poigny S., Franceschi S., Perez E.
Journal of Microencapsulation,
2017, 34, 162-170
.
5. Role of medicines of unknown identity in adverse drug reaction-related hospitalizations in developing countries: evidence from a cross-sectional study in a teaching hospital in the Lao PDR. Caillet C., Sichanh, C., Assemat G., Malet-Martino M., Sommet A., Bagheri H., Sengxeu N., Mongkhonmath N., Mayxay M., Syhakhang L., Lapeyre-Mestre M., Newton P.N., Roussin A.
Drug Safety.
2017, 40 (9), 809-821.
4. New polyaminocarboxylate macrocycles containing phenolate binding units: synthesis, luminescent and relaxometric properties of their lanthanide complexes. Enel M., Leygue N., Balayssac S., Laurent S., Galaup Ch., Vander Elst L., Picard C.
Dalton Transactions. 2017, 46 (14), 4654-4668.
3. Metabolic rewiring in cancer cells overexpressing the glucocorticoid-induced leucine zipper protein (GILZ): Activation of mitochondrial oxidative phosphorylation and sensitization to oxidative cell death induced by mitochondrial targeted drugs. André F., Trinh A., Balayssac S., Maboudou P., Dekiouk S., Malet-Martino M., Quesnel B., Idziorek T., Kluza J., Marchetti P.
The International Journal of Biochemistry & Cell Biology.
2017, 85, 166-174.
2. Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis. Cruz T., Gleizes M., Balayssac S., Mornet E., Marsal G., Millán J.L, Malet-Martino M., Nowak L.G., Gilard V., Fonta C.
Journal of Neurochemistry. 2017, 140, 919-940.
1. A revisited structure for nitrosoprodenafil from NMR, mass spectrometry, X-ray and hydrolysis data. Martino R., Menendez C., Balayssac S., Martins-Froment N., Lherbet C., Couderc F., Gilard V., Malet-Martino M.
J. Pharm. Biomed. Anal. 2017, 135, 39-41.
